GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Farmak PJSC (UKEX:FARM) » Definitions » Piotroski F-Score

Farmak PJSC (UKEX:FARM) Piotroski F-Score : 0 (As of Jun. 23, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Farmak PJSC Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Farmak PJSC has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Farmak PJSC's Piotroski F-Score or its related term are showing as below:


Farmak PJSC Piotroski F-Score Historical Data

The historical data trend for Farmak PJSC's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmak PJSC Piotroski F-Score Chart

Farmak PJSC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 7.00 6.00 5.00 6.00

Farmak PJSC Semi-Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 5.00 6.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec20) TTM:Last Year (Dec19) TTM:
Net Income was ₴1,150 Mil.
Cash Flow from Operations was ₴2,401 Mil.
Revenue was ₴7,515 Mil.
Gross Profit was ₴4,340 Mil.
Average Total Assets from the begining of this year (Dec19)
to the end of this year (Dec20) was (6644.1 + 8427.55) / 2 = ₴7535.825 Mil.
Total Assets at the begining of this year (Dec19) was ₴6,644 Mil.
Long-Term Debt & Capital Lease Obligation was ₴424 Mil.
Total Current Assets was ₴4,094 Mil.
Total Current Liabilities was ₴1,604 Mil.
Net Income was ₴1,057 Mil.

Revenue was ₴6,542 Mil.
Gross Profit was ₴3,715 Mil.
Average Total Assets from the begining of last year (Dec18)
to the end of last year (Dec19) was (5928.982 + 6644.1) / 2 = ₴6286.541 Mil.
Total Assets at the begining of last year (Dec18) was ₴5,929 Mil.
Long-Term Debt & Capital Lease Obligation was ₴330 Mil.
Total Current Assets was ₴3,194 Mil.
Total Current Liabilities was ₴957 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Farmak PJSC's current Net Income (TTM) was 1,150. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Farmak PJSC's current Cash Flow from Operations (TTM) was 2,401. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec19)
=1149.699/6644.1
=0.17304059

ROA (Last Year)=Net Income/Total Assets (Dec18)
=1056.97/5928.982
=0.17827175

Farmak PJSC's return on assets of this year was 0.17304059. Farmak PJSC's return on assets of last year was 0.17827175. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Farmak PJSC's current Net Income (TTM) was 1,150. Farmak PJSC's current Cash Flow from Operations (TTM) was 2,401. ==> 2,401 > 1,150 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec20)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec19 to Dec20
=423.804/7535.825
=0.05623857

Gearing (Last Year: Dec19)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec18 to Dec19
=330.316/6286.541
=0.05254336

Farmak PJSC's gearing of this year was 0.05623857. Farmak PJSC's gearing of last year was 0.05254336. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec20)=Total Current Assets/Total Current Liabilities
=4094.314/1603.546
=2.55328753

Current Ratio (Last Year: Dec19)=Total Current Assets/Total Current Liabilities
=3193.762/956.722
=3.3382341

Farmak PJSC's current ratio of this year was 2.55328753. Farmak PJSC's current ratio of last year was 3.3382341. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Farmak PJSC's number of shares in issue this year was 7.273. Farmak PJSC's number of shares in issue last year was 7.273. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4339.827/7515.344
=0.57746219

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=3714.908/6541.75
=0.56787679

Farmak PJSC's gross margin of this year was 0.57746219. Farmak PJSC's gross margin of last year was 0.56787679. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec19)
=7515.344/6644.1
=1.13113048

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec18)
=6541.75/5928.982
=1.1033513

Farmak PJSC's asset turnover of this year was 1.13113048. Farmak PJSC's asset turnover of last year was 1.1033513. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Farmak PJSC has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Farmak PJSC  (UKEX:FARM) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Farmak PJSC Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Farmak PJSC's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmak PJSC (UKEX:FARM) Business Description

Traded in Other Exchanges
N/A
Address
63 Kyrylivska Street, Kyiv, UKR, 04080
Farmak PJSC is a Ukraine based company engaged in the production and distribution of generic pharmaceutical drugs. Its products include Endocrinology drugs, Diagnostic drugs, Cardiac drugs, and other medications. The products are mainly sold in Ukraine and exported to many other countries.